Zhejiang Sunflower Great Health Limited Liability Company
300111.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -8.35 | -0.10 | 31.40 | -14.98 |
| FCF Yield | 0.44% | -0.19% | -0.49% | 2.34% |
| EV / EBITDA | 423.97 | 102.44 | 269.46 | 48.47 |
| Quality | ||||
| ROIC | 1.51% | 2.80% | 1.20% | 9.93% |
| Gross Margin | 22.47% | 24.70% | 28.64% | 36.63% |
| Cash Conversion Ratio | 2.35 | 0.13 | 5.30 | 1.51 |
| Growth | ||||
| Revenue 3-Year CAGR | -0.55% | 4.41% | 5.39% | -29.17% |
| Free Cash Flow Growth | 349.79% | 58.73% | -121.84% | 166.15% |
| Safety | ||||
| Net Debt / EBITDA | -65.09 | -27.90 | -15.63 | -2.99 |
| Interest Coverage | 6.26 | 4.88 | 6.67 | 195.29 |
| Efficiency | ||||
| Inventory Turnover | 1.79 | 2.16 | 2.13 | 2.51 |
| Cash Conversion Cycle | 117.84 | 102.67 | 118.66 | 257.33 |